Found: 11
Select item for more details and to access through your institution.
Efficacy and Safety of Adalimumab Treatment in Patients with Moderate to Severe Psoriasis: A Double-Blind, Randomized Clinical Trial.
- Published in:
- Psoriasis Forum, 2007, n. 1, p. 4, doi. 10.1177/247553030713a00101
- By:
- Publication type:
- Article
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Petechial eruption on fingers. Dermatitis herpetiformis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Petechial Eruption on Fingers.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 12, p. 1353, doi. 10.1001/jamadermatol.2014.2278
- By:
- Publication type:
- Article
PSORIASIS AND PREGNANCY: HORMONE AND IMMUNE SYSTEM INTERACTION.
- Published in:
- International Journal of Dermatology, 1996, v. 35, n. 3, p. 169, doi. 10.1111/j.1365-4362.1996.tb01632.x
- By:
- Publication type:
- Article
Erythema Ab Igne and Malignant Transformation to Squamous Cell Carcinoma.
- Published in:
- Cutis, 2021, v. 107, n. 1, p. 51, doi. 10.12788/cutis.0145
- By:
- Publication type:
- Article
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 495, doi. 10.1007/s13555-021-00649-y
- By:
- Publication type:
- Article
Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
- Published in:
- International Journal of Dermatology, 2008, v. 47, n. 5, p. 514, doi. 10.1111/j.1365-4632.2008.03470.x
- By:
- Publication type:
- Article
CORRESPONDENCE SUCCESSFUL TREATMENT OF PEDIATRIC PSORIASIS WITH INFLIXIMAB.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Resistant Childhood Psoriasis: An Analysis of Patients Seen in a Day-care Center.
- Published in:
- Pediatric Dermatology, 1984, v. 2, n. 1, p. 8, doi. 10.1111/j.1525-1470.1984.tb00434.x
- By:
- Publication type:
- Article
Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 3879, doi. 10.2147/DDDT.S167149
- By:
- Publication type:
- Article